# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HC Wainwright & Co. analyst Emily Bodnar reiterates Genelux (NASDAQ:GNLX) with a Buy and maintains $32 price target.
Genelux (NASDAQ:GNLX) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.24) by ...
Benchmark analyst Bruce Jackson reiterates Genelux (NASDAQ:GNLX) with a Speculative Buy and maintains $30 price target.
HC Wainwright & Co. analyst Emily Bodnar maintains Genelux (NASDAQ:GNLX) with a Buy and lowers the price target from $35...
Genelux (NASDAQ:GNLX) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.19) by ...
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth...
U.S. stocks traded higher, with the Dow Jones index gaining more than 50 points on Wednesday.